These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14322890)

  • 1. MEASLES IMMUNIZATION: COMBINED VACCINATIONS.
    KRUGMAN S
    Arch Gesamte Virusforsch; 1965; 16():339-42. PubMed ID: 14322890
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES IMMUNIZATION INCORPORATED IN THE ROUTINE SCHEDULE FOR INFANTS: EFFICACY OF A COMBINED INACTIVATED-LIVE VACCINATION REGIMEN.
    KRUGMAN S; STONE S; HU R; FRIEDMAN H
    Pediatrics; 1964 Dec; 34():795-7. PubMed ID: 14243467
    [No Abstract]   [Full Text] [Related]  

  • 3. MEASLES VACCINATION IN ADULTS WITH AND WITHOUT COMPLICATING CONDITIONS.
    GUDNADOTTIR M; BLACK FL
    Arch Gesamte Virusforsch; 1965; 16():521-3. PubMed ID: 14322927
    [No Abstract]   [Full Text] [Related]  

  • 4. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 5. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDY OF THE CAPACITY TO INDUCE REACTIONS AND OF THE IMMUNOLOGIC ACTIVITY OF DIFFERENT VACCINES AGAINST MEASLES.
    BAROYAN OV
    Arch Gesamte Virusforsch; 1965; 16():527-31. PubMed ID: 14322929
    [No Abstract]   [Full Text] [Related]  

  • 7. EXPERIENCE IN THE U.S.S.R. IN THE PREVENTION OF MEASLES BY USE OF LIVE VACCINE.
    BOYCHUK LM; SHIKINA ES; MESHALOVA VN; TAROS LY; AMINOVA MG; REVENOK ND; SAFAROV DI
    Ind Med Surg; 1965 Jan; 34():43-50. PubMed ID: 14267212
    [No Abstract]   [Full Text] [Related]  

  • 8. RESPONSE OF CHILDREN TO MEASLES VACCINE IN ENGLAND.
    CLARKE M
    Arch Gesamte Virusforsch; 1965; 16():351-2. PubMed ID: 14322893
    [No Abstract]   [Full Text] [Related]  

  • 9. MEASLES VACCINATION IN SOUTH AFRICA.
    GRASSET N; GEAR JH
    Arch Gesamte Virusforsch; 1965; 16():254-6. PubMed ID: 14322873
    [No Abstract]   [Full Text] [Related]  

  • 10. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 13. LIVE MEASLES VACCINE TRIALS IN YUGOSLAVIA.
    MILOVANOVIC MV
    Arch Gesamte Virusforsch; 1965; 16():231-42. PubMed ID: 14322869
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin.
    Arbeter AM; Arthur JH; Blakeman GJ; McIntosh K
    J Pediatr; 1972 Oct; 81(4):737-41. PubMed ID: 4116365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 16. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 17. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 20. IMMUNIZATION AGAINST MEASLES: DEVELOPMENT AND EVALUATION OF A HIGHLY ATTENUATED LIVE MEASLES VACCINE.
    SCHWARZ AJ
    Ann Paediatr; 1964; 202():241-52. PubMed ID: 14140673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.